News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,173 Results
Type
Article (87894)
Company Profile (825)
Press Release (780439)
Multimedia
Podcasts (191)
Webinars (28)
Section
Business (233234)
Career Advice (4145)
Deals (39866)
Drug Delivery (145)
Drug Development (91397)
Employer Resources (203)
FDA (18378)
Job Trends (17420)
News (397844)
Policy (39960)
Tag
Academia (3006)
Academic (2)
Accelerated approval (33)
Adcomms (36)
Allergies (142)
Alliances (56981)
ALS (180)
Alzheimer's disease (1783)
Antibody-drug conjugate (ADC) (335)
Approvals (18544)
Artificial intelligence (613)
Autoimmune disease (154)
Automation (34)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (489)
Bladder cancer (159)
Brain cancer (64)
Breast cancer (645)
Cancer (4916)
Cardiovascular disease (433)
Career advice (3567)
Career pathing (40)
CAR-T (300)
CDC (59)
Celiac Disease (1)
Cell therapy (814)
Cervical cancer (37)
Clinical research (76883)
Collaboration (1745)
Company closure (5)
Compensation (1121)
Complete response letters (70)
COVID-19 (2987)
CRISPR (96)
C-suite (825)
Cystic fibrosis (154)
Data (6140)
Decentralized trials (2)
Denatured (70)
Depression (145)
Diabetes (525)
Diagnostics (7207)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (294)
Drug pricing (220)
Drug shortages (36)
Duchenne muscular dystrophy (232)
Earnings (100031)
Editorial (61)
Employer branding (25)
Employer resources (173)
Events (134954)
Executive appointments (1023)
FDA (21447)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1529)
Gene editing (210)
Generative AI (62)
Gene therapy (659)
GLP-1 (1110)
Government (5432)
Grass and pollen (8)
Guidances (382)
Healthcare (20941)
HIV (60)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (287)
Immuno-oncology (52)
Indications (84)
Infectious disease (3271)
Inflammatory bowel disease (202)
Inflation Reduction Act (17)
Influenza (118)
Intellectual property (239)
Interviews (816)
IPO (17952)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (89)
Layoffs (656)
Leadership (39)
Legal (10157)
Liver cancer (97)
Longevity (14)
Lung cancer (671)
Lymphoma (368)
Machine learning (43)
Management (66)
Manufacturing (816)
MASH (171)
Medical device (14999)
Medtech (15043)
Mergers & acquisitions (22949)
Metabolic disorders (1365)
Multiple sclerosis (157)
NASH (23)
Neurodegenerative disease (341)
Neuropsychiatric disorders (93)
Neuroscience (3065)
NextGen: Class of 2026 (7707)
Non-profit (5109)
Now hiring (63)
Obesity (657)
Opinion (331)
Ovarian cancer (162)
Pain (198)
Pancreatic cancer (225)
Parkinson's disease (288)
Partnered (38)
Patents (490)
Patient recruitment (454)
Peanut (60)
People (66814)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23761)
Phase II (33357)
Phase III (25148)
Pipeline (4664)
Policy (329)
Postmarket research (3554)
Preclinical (10682)
Press Release (72)
Prostate cancer (238)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (865)
Real estate (7437)
Recruiting (80)
Regulatory (28857)
Reports (65)
Research institute (2721)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (19)
RSV (83)
Schizophrenia (157)
Series A (254)
Series B (193)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (175)
Sponsored (47)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (111)
Tariffs (98)
The Weekly (119)
Vaccines (1128)
Venture capital (92)
Weight loss (455)
Women's health (85)
Worklife (21)
Date
Today (62)
Last 7 days (690)
Last 30 days (2182)
Last 365 days (33172)
2026 (1486)
2025 (33226)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (87)
Alaska (7)
Arizona (339)
Arkansas (14)
Asia (51483)
Australia (9033)
California (11314)
Canada (3257)
China (1129)
Colorado (477)
Connecticut (492)
Delaware (340)
Europe (118286)
Florida (1655)
Georgia (363)
Hawaii (3)
Idaho (68)
Illinois (941)
India (65)
Indiana (533)
Iowa (23)
Japan (412)
Kansas (132)
Kentucky (42)
Louisiana (29)
Maine (82)
Maryland (1439)
Massachusetts (8374)
Michigan (349)
Minnesota (649)
Mississippi (6)
Missouri (137)
Montana (35)
Nebraska (28)
Nevada (122)
New Hampshire (85)
New Jersey (3061)
New Mexico (33)
New York (3001)
North Carolina (1584)
North Dakota (10)
Northern California (5394)
Ohio (347)
Oklahoma (22)
Oregon (54)
Pennsylvania (2267)
Puerto Rico (20)
Rhode Island (49)
South America (1657)
South Carolina (62)
South Dakota (1)
Southern California (4355)
Tennessee (173)
Texas (1786)
United States (40944)
Utah (339)
Vermont (1)
Virginia (283)
Washington D.C. (85)
Washington State (949)
West Virginia (4)
Wisconsin (122)
Wyoming (2)
There are 869,173 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug pricing
Trump Takes Drug Pricing Fight To Insurers With ‘The Great Healthcare Plan’
Incoming PhRMA Chair Paul Hudson, a day before the White House announcement, pledged to work with the administration as the president turns to insurers as a source of cost savings for prescription medicines.
January 15, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Samsung Epis Holdings Delivers Business Updates at the 44th J.P. Morgan Healthcare Conference
January 15, 2026
·
5 min read
Press Releases
Vetter reaches key launch milestones for the V-OVS® next tamper-evident syringe closure system
Several recent steps move the closure toward commercialization: · New studies confirm the system’s usability and performance · Design now finalized and preparations for industrialization underway · Multiple new features set a new standard for luer lock closure systems
January 15, 2026
·
1 min read
Press Releases
Scryb Inc. Provides Early Warning Update on Holdings in Cybeats Technologies Corp.
January 15, 2026
·
5 min read
Press Releases
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology
Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for Enhanced Diagnostic Capabilities
January 15, 2026
·
4 min read
Press Releases
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026
Registration Link for Phio’s Presentation on Thursday, January 22 at 1:45 PM ET
January 15, 2026
·
5 min read
FDA
FDA Delays Decision for Lilly’s Obesity Pill Orforglipron, Other Priority Voucher Awardees: Report
Target action dates for drugs sponsored by Sanofi, Boehringer Ingelheim and Disc Medicine have also been pushed back despite assurances of swift reviews under the FDA’s new Commissioner’s National Priority Voucher program.
January 15, 2026
·
1 min read
·
Tristan Manalac
Legal
Compounder Sues Lilly, Novo, Claims Coordinated Crackdown
Strive Compounding Pharmacy alleged in its lawsuit that Eli Lilly and Novo Nordisk have worked to lock telehealth providers in exclusive partnerships, disallowing them from offering compounded versions of GLP-1 medicines.
January 15, 2026
·
2 min read
·
Tristan Manalac
Business
Jazz Sells Priority Review Voucher for $200M as Program’s Renewal Languishes in Senate
Half of the net proceeds will go to Jazz; it remains unclear who will get the remaining sum. Jazz did not reveal the buyer of the voucher.
January 15, 2026
·
2 min read
·
Tristan Manalac
Rare diseases
JPM Day 3: Rare Disease in the Spotlight
2026 is shaping up to be a pivotal year for rare disease drugmakers, with key approvals, filings and readouts lined up for this year.
January 15, 2026
·
5 min read
·
Tristan Manalac
1 of 86,918
Next
